Lipoprotein lipase appears to function as the mechanism by which dietary vitamin E (tocopherol) is transferred from chylomicrons to tissues. In patients with lipoprotein lipase deficiency, more than 85% of both the circulating triglyceride and tocopherol is contained in the chylomicron fraction. The studies presented here show that the in vitro addition of bovine milk lipoprotein lipase (lipase) to chylomicrons in the presence of human erythrocytes or fibroblasts (and bovine serum albumin [BSAJ) resulted in the hydrolysis of the triglyceride and the transfer of both fatty acids and tocopherol to the cells; in the absence of lipase, no increase in cellular tocopherol was detectable. The incubation system was simplified to include only fibroblasts, BSA, and Intralipid (an artificial lipid emulsion containing 10% soybean oil, which has gamma but not alpha tocopherol). The addition of lipase to this system also resulted in the transfer of tocopherol (gamma) to the fibroblasts. Addition of both lipase and its activator, apolipoprotein CII, resulted in a further increase in the cellular tocopherol content, but apoliprotein CHI alone had no effect. Heparin, which is known to prevent the binding of lipoprotein lipase to the cell surface membrane, abrogated the transfer of tocopherol to fibroblasts without altering the rate of triglyceride hydrolysis. Thus, in vitro tocopherol is transferred to cells during hydrolysis of triglyceride by the action of lipase, and for this transfer of tocopherol to occur, the lipase itself must bind to the cell membrane.
Introduction Vitamin E (alpha tocopherol) deficiency has been described in patients with various lipid malabsorption syndromes, including: abetalipoproteinemia (1, 2) , cholestatic liver disease (3), and short bowel syndrome (4) . In 1967, Kayden recommended dietary supplementation with vitamin E for patients with abetalipoproteinemia (2) . The malabsorption syndrome in these genetically affected subjects is a result of their inability to synthesize apolipoprotein B; these patients are thus unable to secrete chylomicrons, very low or low density lipoproteins (VLDL or LDL, respectively). Patients with abetalipoproteinemia have low levels of circulating lipids, as well as low levels of plasma tocopherol, despite supplemental vitamin E (1). However, those patients, who have been supplemented with vitamin E, have minimal or absent neurological abnormalities, but those who have not been supplemented have a progressive degeneration of the peripheral nervous system resulting in ataxia and characteristic pathologic changes in the central nervous system (5) . These neuropathologic changes have been observed in patients with cholestatic liver disease in whom the low to absent levels of bile salts in the intestine results in an inability to absorb vitamin E (3). Oral supplementation with pharmacologic amounts of the vitamin (6) , or pagenteral administration of the vitamin (when there is a complete absence of intestinal bile) (7) results in the prevention of further deterioration of the nervous system. The studies in these two groups of patients have demonstrated the importance of bile acids and chylomicron formation for the absorption of dietary vitamin E and its transport in the plasma. The studies described in this report were undertaken in an effort to describe how tocopherol is transferred from the plasma to the tissues.
Tocopherol is present in normal individuals in all of the plasma lipoprotein fractions; no specific carrier has been reported for the vitamin (8) . Previously, we have demonstrated that the tocopherol present in LDL or high density lipoprotein (HDL) readily transfers to erythrocytes, when incubated together in vitro (9) . Furthermore, we have recently reported that the tocopherol present in LDL is delivered to fibroblasts via the high affinity receptor for LDL (10) .
In contrast to the ease with which tocopherol can exchange when it is present in LDL or HDL, the tocopherol present in VLDL exchanged poorly in the experimental system (9) . In patients who are deficient in lipoprotein lipase (type I), >85% of the circulating tocopherol and triglyceride is confined to lipoproteins with densities <1.006 g/ml, presumably chylomicrons and VLDL (1) . Lipoprotein lipase is known to hydrolyze triglyceride to free fatty acids and transfer the fatty acids to tissues (for review, see I 1). This enzyme can also mediate the transfer of cholesteryl esters (12) CO2. Confluent monolayers of cells in 25 cm2 flasks were used for the incubations, which are described below.
Isolation ofchylomicrons. Patients with hypertriglyceridemia (serum triglycerides in excess of 1,000 mg/dl), normal levels of apolipoprotein CII, and absent lipoprotein lipase activity after intravenous injection of heparin were donors of "chylomicrons." Plasma (30 ml) from each patient was isolated from whole blood, then spun without change in density for 1 h at 100,000 g. The d < 1.006 g/ml layer was isolated, and is called "chylomicrons" for the purposes of these experiments.
Preparation oferythrocytes. Erythrocytes were isolated from whole blood donated by normal volunteers by centrifugation for 10 min at 2,000 rpm. The plasma and buffy coat were discarded and the erythrocytes washed three times with phosphate-buffered saline, pH 7.4, as previously described (14) .
Preparation of radioactive intralipid. Glyceryl-tri(stearate 9,10-3H) (Nuclear Chicago Corp., Des Plaines, IL) was plated onto silica gel G, the plate developed in petroleum ether/ethyl ether/acetic acid (83:16: 1), the triglyceride fraction identified, and the silica gel scraped and extracted with chloroform. An aliquot of the chloroform containing -2 X 10' cpm was dried down in a scintillation vial, then -5 ml Intralipid was added, and the sample stirred overnight at room temperature. Approximately 10% of the radioactivity was exchanged onto the Intralipid by this procedure.
Bovine milk lipoprotein lipase. The lipase was isolated as described previously (15) . It was kept frozen at -60'C and defrosted on ice immediately before use.
Cell incubation protocol. Fibroblasts (washed once in the flask with DMEM) or erythrocytes (isolated as described above) were incubated for I h with chylomicrons with or without lipase in the presence of 7.5% bovine serum albumin (BSA) in DMEM at pH 7.4 for Table I. For Fig. 1 , the standard protocol (described below) was used with the addition of chylomicrons.
The standard protocol was carried out with defined components. Fibroblasts were washed, then I ml of DMEM was added to the flask, followed by 3 ml substrate (radioactive Intralipid [1 ml/3 ml substrate] in DMEM with BSA; final BSA concentration was 4%, i.e., 160 mg/4 ml). In the studies where heparin (1,000 USP units/ml; O'Neal, Jones & Feldman, St. Louis, MO) and/or apolipoprotein CII (a gift from Richard Jackson, University of Cincinnati College of Medicine, Cincinnati, OH) were included in the incubation system, each was added after the substrate, but before the lipase. The apolipoprotein CII was added in a total volume of 50 til of guanidine buffer (6 M guanidine HCG, 10 mM Tris, pH 8.0); the guanidine buffer was also added without apolipoprotein CII to all flasks in those experiments where the effect of apolipoprotein CII was studied. The amount of apolipoprotein CII used was 160 ug, 20 times the amount of lipase, as has previously been described using an incubation system with Intralipid (16) . The amounts of heparin used were as described by Chajek-Shaul et al. (13) .
Following the addition of all of the components to the flasks, the frozen bovine milk lipoprotein lipase was defrosted on ice, then immediately diluted with Intralipid (the total amount of Intralipid added was I ml/flask; a portion was reserved when making the substrate for the dilution of the Intralipid), and aliquoted into the flasks containing cells and substrate. The flasks were placed in the dark in a shaker at 100 rpm and incubated at room temperature for I h. At the end of the incubation, the medium was poured off and analyzed for the extent of triglyceride hydrolysis (see below), and the cells were analyzed for their tocopherol and protein contents (see below).
Tocopherol in cells. To prevent destruction of the tocopherol, all of the following procedures were carried out under subdued light. Fibroblasts were washed thoroughly with ice-cold buffer C (50 mM Tris, 0.15 M NaCl, 2 mg/ml BSA), then with buffer D (C without BSA), and were scraped from the flasks (17) . The same buffers were used to wash erythrocytes, except the erythrocytes were washed with an equal volume of buffer by inverting the tube; then the tube was centrifuged briefly, the excess buffer removed, and the hematocrit measured. Aliquots of the cells were taken for the determination of protein by the method of Lowry et al. (18) , for scintillation counting to measure the uptake of labeled fatty acids, and for measurement of tocopherol content following saponification (19) . Briefly, the cells were saponified at 70'C with alcoholic KOH in the presence of 1% ascorbic acid for 30 min, then extracted with hexane. The hexane was aliquoted, dried down, and the residue dissolved in methanol with 1% ascorbic acid. The alpha and gamma tocopherol contents of the methanol were measured by injecting the methanol using the Waters Intelligent Sample Processor into the high performance liquid chromatography system, and detected by fluoresence (excitation, 205 nm; emission, 340 nm) as described previously (19) . As little as 1 ng of either alpha or gamma tocopherol could be measured accurately following this protocol.
Triglyceride hydrolysis. For the measurement of the free fatty acid content of the medium, the medium was poured directly into 15 ml of stopping solution (heptane/chloroform/methanol [1:1.25:1.4] containing ["C]oleic acid, -8 X 106 cpm/ml), and shaken vigorously for 1 min, as described by Belfrage and Vaughan (20) . Then, 1 ml of 1 N NaOH was added, and the samples were shaken for I h. At the end of the extraction period, the tubes were spun in a centrifuge for 10 min at 2,500 rpm to separate the two layers. An aliquot (6 ml) of the upper methanol/water layer was acidified with 100 Ml concentrated HCI, and then extracted with heptane (6 ml) by shaking for I h. Following the extraction period, 2.5 ml of 50% TCA was added, and then the tubes spun as before. (The TCA is added to precipitate the large amounts of albumin present, which otherwise remained at the heptane/methanol interface. Any fatty acids which might be trapped by the TCA are corrected for by the recovery of the internal standard.)
Aliquots of the heptane were taken for counting (100 tl) and for methylation (5 ml).
To methylate the samples, the heptane was dried down and 0.5 ml of 5% H2S04 in methanol with 1% benzene was added and the samples incubated overnight at 60°C. The methyl esters of the fatty acids were then extracted with petroleum ether and aliquoted for counting (for recovery of the "4C) and for fatty acid quantitation, such that the samples contained between 0.5 and 2.0 zmol fatty acid, and then the samples were dried down. 3 ml of alcohol/ether (3:1) was added to each of the dried samples and 0.5 ml of 2 M hydroxylamine and 0.5 ml 3.5 N NaOH were added; following vigorous mixing, the samples were allowed to stand 20 min at room temperature. Then, 0.6 ml of 4 N HCG and 0. gamma tocopherol transferred to the cells at least as well as alpha tocopherol at all levels of lipase tested. Fig. 2 shows the results of a representative experiment in which Intralipid served as the sole source of both triglycerides and tocopherol: 2 A shows the amount of gamma tocopherol transferred to cells, 2 B shows the fatty acids transferred (determined from the radioactivity present in the cells), 2 C shows the hydrolysis of triglyceride, expressed as fatty acid released (determined from the radioactivity in the free fatty acids extracted from the medium). The tocopherol content of cells, fatty acids transferred and fatty acids released were all observed to increase with the addition of increasing amounts of lipoprotein lipase added to the incubation system, demonstrating that the transfer of tocopherol to cells occurred in the absence of apolipoproteins.
As apolipoprotein CII is an activator of the lipoprotein lipase enzyme, its effect on tocopherol transfer was tested in the incubation system. The simultaneous addition of both lipase and apolipoprotein CII to the medium resulted in a nearly sixfold increase in the tocopherol transferred compared with the transfer due to incubation with lipase alone (Table  II normal fibroblasts and LDL receptor-negative fibroblasts from a subject with the homozygous form of familial hypercholesterolemia were tested using this protocol; the results were similar in both types of fibroblasts. The data shown in Fig. 3 is from the LDL receptor-negative fibroblasts. In the absence of heparin, the amount of tocopherol transferred was the same (8 ug Fig. 3 C, the rate of triglyceride hydrolysis was constant and was not affected by the presence of heparin in the incubation mixture at any of the concentrations of heparin used. Therefore, for tocopherol to transfer to cells, the lipase must bind to the cell membrane. It is apparent that the presence of the products of hydrolysis or the changes in conformation of the remnants of the lipid droplet are not sufficient for the transfer of tocopherol. The inhibitory effect of heparin on the transfer of tocopherol could not be overcome by stimulating the lipase activity by the addition of apolipoprotein CII. As shown in Table III , although the simultaneous addition oflipase with apolipoprotein CII to the incubation system with normal fibroblasts resulted in the transfer of 95 pmol of tocopherol to the cells, the addition of heparin to the incubation system, followed by the simultaneous addition of lipase and apolipoprotein CII, resulted in 9.6 pmol transferred, a nearly 10-fold decrease in the transfer of tocopherol to the cells. (It should be noted that the higher amount of tocopherol transferred shown in Table III as compared with the data in Table II The demonstration that lipoprotein lipase itself was the agent transferring tocopherol was made in an incubation system that included only fibroblasts, 4% BSA in DMEM, and Intralipid (an artificial emulsion containing 10% soybean oil, which has gamma but not alpha tocopherol). This system has the advantage of containing no apolipoproteins and any tocopherol transferred is gamma, which is usually not present in the fibroblasts. Again, the addition of lipase to this system resulted in the mass transfer of tocopherol (gamma) to the fibroblasts (Fig. 2) . Addition of apolipoprotein CII and the lipase to the incubation system resulted in a further increase in the cellular tocopherol content (Table II) .
We also demonstrated that the addition of heparin to the incubation system abrogates the transfer of tocopherol to fibroblasts without altering the rate of triglyceride hydrolysis (Fig. 3) . Furthermore, in the presence of heparin, apolipoprotein CII added to the incubation system did not restore the transfer of tocopherol to fibroblasts (Table III) Kayden (1) has reported that the adipose tissue tocopherol levels in adult subjects with lipoprotein lipase deficiency were low but within normal range, while plasma levels were more than twice normal. The tocopherol content of the child's plasma, following removal of chylomicrons by ultracentrifugation at 100,000 g for 1 h, was 2.9 Ag/ml; as normal individuals do not have chylomicrons present in their plasma, her nonchylomicron, non-VLDL value can be compared with the normal plasma level (7-10 /Ag/ml). It should be noted that the distribution of tocopherol in lipoproteins of normal subjects is primarily in LDL and HDL (8) . We have recently demonstrated that the high affinity receptor for LDL also serves to deliver tocopherol to cells (10) . Thus, there appears to be redundant mechanisms for the delivery of both peroxidizable lipids and an antioxidant, tocopherol, to the tissues. In the lipoprotein lipase-deficient child, the low levels of tocopherol in the adipose tissue and in the "LDL and HDL" fraction of the plasma reflect the sharp restriction of dietary fat, which limits the intake of vitamin E. Thus, the adipose tissue of the patient contains a low concentration of tocopherol due to both a low level of tocopherol in the LDL fraction, which limits the ability of the LDL receptor pathway to deliver vitamin E to the tissues, and the inability of the patient to utilize the tocopherol present in the chylomicron and VLDL fraction, which do not easily undergo lipolysis due to the absence of lipoprotein lipase. The data from this child warrants us to recommend oral supplementation with vitamin E for patients with lipoprotein lipase deficiency.
We have also measured the adipose tissue tocopherol content in a patient with a reduced level of LDL receptors. In this adult male (age 46) with the diagnosis of the heterozygous form of hypercholesterolemia (type 2 a), his adipose tissue tocopherol level was 209 ng E/mg triglyceride, while his plasma level was 13 gg tocopherol/ml. Although the plasma tocopherol in this patient was elevated, a reflection of the elevated LDL levels, the adipose tissue was at a normal level.
The in vitro studies were carried out to attempt to determine mechanisms involved in the transfer of tocopherol to tissues. The physiological importance of the two pathways is only suggestive at this time; the observations in the patients with various disorders of lipoprotein metabolism do lend credence to our hypotheses that both the lipoprotein lipase pathway and the LDL receptor pathway are important for the delivery of tocopherol to tissues in vivo. From our data it is not possible to extrapolate to give an estimate of the importance of each pathway in vivo. Under the conditions of our studies, using the optimal levels of transfer for each mechanism, the transfer of tocopherol to fibroblasts via the lipoprotein lipase pathway appears to be more than 10-fold the amount transferred via the LDL receptor pathway.
